Literature DB >> 24526234

Review: epidemiology and pathophysiology of atypical femur fractures.

Alvin C Ng1, Meng Ai Png, David T Chua, Joyce S B Koh, Tet Sen Howe.   

Abstract

The recent recognition of the clinical phenomenon of atypical femoral fractures has garnered significant scientific interest. In this review, we will discuss and summarize the salient developments in the current understanding of the epidemiology, pathophysiology, and radiology of atypical femoral fractures.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24526234     DOI： 10.1007/s11914-014-0198-z

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN： 1544-1873            Impact factor:   5.096


  80 in total

1.  Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features.

Authors:  Sarah Shock Chan; Zehava Sadka Rosenberg; Keith Chan; Craig Capeci
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

2.  Effects of non-enzymatic glycation on cancellous bone fragility.

Authors:  S Y Tang; U Zeenath; D Vashishth
Journal:  Bone       Date:  2006-12-21       Impact factor: 4.398

3.  Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology.

Authors:  J S B Koh; S K Goh; M A Png; A C M Ng; T S Howe
Journal:  Singapore Med J       Date:  2011-02       Impact factor: 1.858

4.  Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?

Authors:  Yong-Chan Ha; Myung-Rae Cho; Ki Hong Park; Shin-Yoon Kim; Kyung-Hoi Koo
Journal:  Clin Orthop Relat Res       Date:  2010-09-24       Impact factor: 4.176

5.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

6.  Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.

Authors:  Roland D Chapurlat; Monique Arlot; Brigitte Burt-Pichat; Pascale Chavassieux; Jean Paul Roux; Nathalie Portero-Muzy; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

7.  Atypical femur fractures: 81 individual personal histories.

Authors:  Jennifer P Schneider; William B Hinshaw; Christina Su; Phyllis Solow
Journal:  J Clin Endocrinol Metab       Date:  2012-10-17       Impact factor: 5.958

8.  Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Sundeep Khosla; David Burr; Jane Cauley; David W Dempster; Peter R Ebeling; Dieter Felsenberg; Robert F Gagel; Vincente Gilsanz; Theresa Guise; Sreenivas Koka; Laurie K McCauley; Joan McGowan; Marc D McKee; Suresh Mohla; David G Pendrys; Lawrence G Raisz; Salvatore L Ruggiero; David M Shafer; Lillian Shum; Stuart L Silverman; Catherine H Van Poznak; Nelson Watts; Sook-Bin Woo; Elizabeth Shane
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

9.  Atypical femoral fractures: transverse morphology at lateral cortex is a critical feature.

Authors:  Alvin C Ng; Meng Ai Png; P Chandra Mohan; Joyce S B Koh; Tet Sen Howe
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

Review 10.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616
View more
  4 in total

Review 1.  A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.

Authors:  R Dell; D Greene
Journal:  Osteoporos Int       Date:  2018-04-19       Impact factor: 4.507

2.  ATYPICAL FEMORAL FRACTURES DUE TO THE USE OF BISPHOSPHONATES: EPIDEMIOLOGIC STUDY IN A TERTIARY HOSPITAL.

Authors:  Fernanda DA Costa Golfieri; Maurício Zanon; Pedro Paulo Verona Percio
Journal:  Acta Ortop Bras       Date:  2022-04-15       Impact factor: 0.683

3.  The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.

Authors:  Joan C Lo; Rita L Hui; Christopher D Grimsrud; Malini Chandra; Romain S Neugebauer; Joel R Gonzalez; Amer Budayr; Gene Lau; Bruce Ettinger
Journal:  Bone       Date:  2016-01-06       Impact factor: 4.398

4.  Atypical femoral fracture due to chronic use of bisphosphonates: case report.

Authors:  Eduardo Frois Temponi; Lúcio Honório de Carvalho Junior; Lincoln Paiva Costa
Journal:  Rev Bras Ortop       Date:  2015-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.